This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of a Case and Review of the Literature

CAPT. N. DAVID CHARKES, MC

AMA Arch Intern Med. 1958;102(4):584-593.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Meprobamate (Miltown, Equanil) was synthesized in 1950 by Ludwig and Piech in an effort to find a muscle relaxant with longer duration of action and fewer side-effects than mephenesin.¹ In the initial pharmacological evaluation, Berger discovered three unusual attributes of meprobamate which account in some part for its effectiveness as a tranquilizing agent, namely: (1) muscle relaxation due to selective blockage of interneuronal synapses but without effect on monosynaptic reflexes, impulse transmission in peripheral nerves, or activity at the neuromuscular junction; (2) peculiar "taming" effect on monkeys in that aggression disappears, and (3) thalamic stimulation.² Although the drug has been in clinical use since 1954, reports of toxicity have been scattered, and only one review of adverse responses has appeared.³ One death has been reported.⁴ The purpose of this communication is to present a case of meprobamate idiosyncrasy with skin biopsy and skin testing, to review . . . [Full Text PDF of this Article]

Author Affiliations
U. S. Army

Dr. Charkes now Assistant Resident in Medicine, University Hospital, Baltimore.

Footnotes
Submitted for publication Feb. 13, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?